including rAAV8.hRKp.AIPL1 for LCA4 - Received from HPRA and MHRA additional clinical and commercial licensures in Ireland and UK for Shannon and London GMP viral vector manufacturing facilities ...

The Company combines two world leading platforms, in precision target discovery and in high efficiency, vector delivery systems ... products Regulatory Agency (MHRA) in 2022.

With these truly exceptional clinical results in hand, along with our in-house manufacturing process, we anticipate filing with the UK's Medicines and Healthcare products Regulatory Agency (MHRA ...

Presenting new technologies, specific case studies, updates on GMP, MHRA regulatory guidelines, quality control and therapeutic applications of stem cells, pre-clinical and clinical trial design ...

The gene therapy involves injecting functional copies of the AIPL1 gene into the retina using an adeno-associated viral (AAV) vector ... Regulatory Agency (MHRA) and plans to submit AAV-AIPL1 ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) isn't sufficiently funded to meet its obligations, according to a new report commissioned by a pharma trade organisation.

Lawrence Tallon has been named as the new Chief Executive Officer of Medicines and Healthcare products Regulatory Agency (MHRA). In response to the announcement, Richard Torbet, Chief Executive of the ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to protect adults aged 60 years and older against lower ...

The international research collaboration also included researchers from the University of Oxford, the Medicines and Healthcare products Regulatory Agency (MHRA), the John Innes Center, The ...